Regulatory Disapproval. The contemplated effective date for the Registration Statement as described in Section 1.1(b) shall be extended without default or liquidated damages hereunder or under the Purchase Agreement in the event that the Company’s failure to obtain the effectiveness of the Registration Statement on a timely basis results solely from the Commission’s disapproval of the structure of the transactions contemplated by the Purchase Agreement. In such event, the parties agree to cooperate with one another in good faith to arrive at a resolution acceptable to the Commission.
Regulatory Disapproval. The contemplated effective date for the Registration Statement as described in Section 1.1(b) shall be extended without default or liquidated damages hereunder or under the Purchase Agreement in the event that the Company’s failure to obtain the effectiveness of the Registration Statement on a timely basis results from (i) the failure of the Investor to timely provide the Company with information requested by the Company and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act, or (ii) the Commission’s disapproval of the structure of the transactions contemplated by the Purchase Agreement, or (iii) events or circumstances that are not in any way attributable to the Company. In the event of clause (ii) above, the parties agree to cooperate with one another in good faith to arrive at a resolution acceptable to the Commission.
Regulatory Disapproval. If the Consumer Finance Protection Bureau, Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System, the Office of Mortgage Settlement Oversight and/or the Monitoring Committee of the National Mortgage Settlement disapprove this Settlement Agreement before the Trustees’ Acceptance Date, or performance of this Settlement Agreement by JPMorgan otherwise becomes legally impossible, JPMorgan, with the consent of the Accepting Trustees (such consent not to be unreasonably withheld) shall have the right to terminate this Settlement Agreement.
Regulatory Disapproval. Notwithstanding the provisions of Sections 1.1 (b), the date by which a Registration Statement is required to become effective shall be extended without default or liquidated damages hereunder or under the Purchase Agreement in the event that the Company's failure to obtain the effectiveness of the Registration Statement on a timely basis results solely from the Commission's disapproval of the structure of the transactions contemplated by the Purchase Agreement. In such event, the parties agree to cooperate with one another in good faith to arrive at a resolution acceptable to the Commission; PROVIDED, HOWEVER, that nothing contained in this subsection 1.1(c) shall relieve the Company from its obligation to effect and maintain the registration of the Warrant Shares on a timely basis.
Regulatory Disapproval. Any application required for Regulatory Approval of the transactions contemplated by this Agreement shall have been denied and the time period for appeals and requests for reconsideration shall have run;
Regulatory Disapproval. At any time if either party has been informed in writing by a regulatory authority whose approval or consent is required that such approval or consent is unlikely to be granted, unless the failure of such occurrence shall be due to the failure of Colonial to perform or observe its agreements set forth herein required to be performed or observed by it on or before the Closing; or
Regulatory Disapproval. If the Consumer Finance Protection Bureau, Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System, the Office of Mortgage Settlement Oversight and the Monitoring Committee of the National Mortgage Settlement disapprove this Settlement Agreement before the Trustees’ Acceptance Date, or performance of this Settlement Agreement otherwise becomes legally impossible, Citigroup and the Institutional Investors shall have the right to terminate this Settlement Agreement.
Regulatory Disapproval. Either party may terminate this Agreement by written notice to the other party if any regulatory agency whose approval is required disapproves this transaction, unless an appropriate appeal or challenge to the disapproval is initiated within 30 days after the disapproval and pursued diligently, to a conclusion.
Regulatory Disapproval. The contemplated effective date for the Registration Statement as described in Section 1.1(b) shall be extended without default or liquidated damages hereunder or under the Purchase Agreement (and without the ability of the Investor to terminate the Purchase Agreement pursuant to Section 8.2(b) thereof) in the event that the Company’s failure to obtain the effectiveness of the Registration Statement on a timely basis results from (i) the failure of the Investor to timely provide the Company with information requested by the Company and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act, or (ii) the Commission’s disapproval of the structure of the transactions contemplated by the Purchase Agreement, or (iii) a determination by the Commission (including any initial determination included in any Commission staff comment letter received by the Company with respect to the Registration Statement) that either the Company or the Investor is ineligible to rely on Rule 415 under the Securities Act with respect to (or that Rule 415 is otherwise unavailable or may not be relied upon with respect to) the registration of any or all of the Registrable Securities for resale by the Investor, or (iv) events or circumstances that are not in any way attributable to the Company. In the event of clauses (ii) and (iii) above, the parties agree to cooperate with one another in good faith to arrive at a resolution acceptable to the Commission.
Regulatory Disapproval. The contemplated effective date for the Registration Statement as described in Section 1.1(b) shall be extended without default or liquidated damages hereunder or under the Purchase Agreement in the event that the Company's failure to obtain the effectiveness of the Registration Statement on a timely basis results from (i) the failure of the Investor to provide the Company with information requested by the Company and necessary to complete the Registration Statement by the Filing Date, (ii) the Commission's disapproval of the structure of the transactions contemplated by the Purchase Agreement, (iii) the Commission failing to respond within a customary time period to the filing of the Registration Statement or any post filing communications from the Company, or (iv) events or circumstances that are not in any way attributable to the Company; provided, that the Company has complied and continues to comply with its obligation to use commercially reasonable efforts to cause the Registration Statement to become effective. In the event of clause (ii) above, the parties agree to cooperate with one another in good faith to arrive at a resolution acceptable to the Commission.
